In 2017, the Seventieth World Health Assembly adopted resolution WHA70. 12 on Cancer
prevention and control in the context of an integrated approach (Appendix A). Operative …

Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …

Why Are Biosimilars Not Living up to Their Promise in the US? | Journal of Ethics | American
Medical Association Skip to main content AMA Journal of Ethics ® Illuminating the Art of …

Healing an ailing pharmaceutical system: prescription for reform for United States and Canada
Page 1 Healing an ailing pharmaceutical system: prescription for reform for United States and …

Highlights•Most new drugs receive a patent term restoration (PTR) extension.•Patents with
PTR commonly expire more than 12 years after marketing approval.•Patents with PTR …

Importance High and continually increasing pharmaceutical drug spending is a major health
and health policy concern in the United States. Objective To demonstrate trends in prices …

Brand‐name drugs have periods of market exclusivity before generic competition begins.
Due to high brand‐name drug prices charged during this period, market exclusivity is an …

Importance The high and increasing expenditures for prescription medications in the US is a
national problem. Objective To explore the association of generic statin competition on …

The literature on pharmaceutical marketing devotes little attention to the promotion of
branded drugs after generic competitors enter the market. This paper addresses this gap in …

Methods| In this cohort study, we identified all first generic drug approvals in the US from
2015 through 2019. We excluded over-the-counter drugs and, because not all generic drugs …